Fennec Pharmaceuticals (FENC) News Today $5.99 +0.15 (+2.57%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period What is HC Wainwright's Estimate for FENC FY2024 Earnings?December 21 at 1:37 AM | americanbankingnews.comFennec's Pedmarqsi gets nod from U.K. regulatorsDecember 20 at 7:28 PM | msn.comFennec announces Pedmarqsi positive recommendation by NICEDecember 20 at 2:28 PM | markets.businessinsider.comFennec Pharmaceuticals (NASDAQ:FENC) Given Outperform Rating at WedbushWedbush reiterated an "outperform" rating and issued a $13.00 price objective on shares of Fennec Pharmaceuticals in a research report on Friday.December 20 at 10:27 AM | marketbeat.comFennec' Pedmarqsi Gets Support From NICE For Cisplatin-Induced Hearing Loss PreventionDecember 20 at 9:27 AM | markets.businessinsider.comFennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and WalesDecember 20 at 6:16 AM | globenewswire.comHC Wainwright Has Bearish Forecast for FENC FY2024 EarningsFennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - HC Wainwright lowered their FY2024 earnings estimates for Fennec Pharmaceuticals in a report issued on Tuesday, December 17th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.13) per share for the year, downDecember 19 at 10:02 AM | marketbeat.comFennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital ManagementDecember 19 at 6:13 AM | globenewswire.comOptimistic Growth Prospects for Fennec Pharmaceuticals Amidst Financial ChallengesDecember 18 at 5:11 AM | markets.businessinsider.comFennec Pharmaceuticals' (FENC) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $13.00 price target on shares of Fennec Pharmaceuticals in a research report on Tuesday.December 17, 2024 | marketbeat.comFennec Pharmaceuticals to Participate in Upcoming Investor ConferenceDecember 12, 2024 | financialpost.comFennec Pharmaceuticals to Participate in Upcoming Investor ConferenceDecember 12, 2024 | financialpost.comFennec Pharmaceuticals to Participate in Upcoming Investor ConferenceDecember 12, 2024 | globenewswire.comInsider Sell: Rosty Raykov Sells Shares of Fennec Pharmaceuticals Inc (FENC)December 4, 2024 | gurufocus.comFennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells $39,351.26 in StockDecember 3, 2024 | insidertrades.comFennec Pharmaceuticals (NASDAQ:FENC) Rating Increased to Strong-Buy at StephensStephens raised Fennec Pharmaceuticals to a "strong-buy" rating in a research note on Monday.November 20, 2024 | marketbeat.comFennec initiated with an Overweight at StephensNovember 18, 2024 | markets.businessinsider.comFennec Pharmaceuticals to Participate in Upcoming Investor ConferenceNovember 13, 2024 | globenewswire.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | msn.comResearch Analysts Offer Predictions for FENC FY2025 EarningsFennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Research analysts at Wedbush cut their FY2025 earnings estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Thursday, November 7th. Wedbush analyst D. Nierengarten now anticipates that the company will earn $0.05November 11, 2024 | marketbeat.comFennec Pharmaceuticals Inc. (FENC) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comFennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...November 9, 2024 | finance.yahoo.comFennec Pharmaceuticals Reports Q3 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comFennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 7, 2024 | globenewswire.comInsider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells 2,431 Shares of StockNovember 5, 2024 | insidertrades.comFennec Pharmaceuticals (FENC) Scheduled to Post Quarterly Earnings on ThursdayFennec Pharmaceuticals (NASDAQ:FENC) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.November 1, 2024 | marketbeat.comFennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024October 31, 2024 | globenewswire.comFennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of GrowthOctober 28, 2024 | markets.businessinsider.comFennec Pharmaceuticals Appoints CMO, CCO, And CSOOctober 28, 2024 | markets.businessinsider.comFennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of GrowthOctober 28, 2024 | globenewswire.comQ3 EPS Estimates for FENC Boosted by Capital One FinancialFennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Analysts at Capital One Financial lifted their Q3 2024 earnings per share estimates for Fennec Pharmaceuticals in a report issued on Wednesday, October 16th. Capital One Financial analyst N. Quibria now forecasts that the company will earnOctober 21, 2024 | marketbeat.comFennec: Operational Challenges Persist Despite Improved Financial PositionOctober 7, 2024 | seekingalpha.comFennec Pharmaceuticals (NASDAQ:FENC) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comFennec Pharmaceuticals Inc (NASDAQ:FENC) Director Sells $12,009.14 in StockOctober 2, 2024 | insidertrades.comThe past three years for Fennec Pharmaceuticals (NASDAQ:FENC) investors has not been profitableOctober 1, 2024 | finance.yahoo.comFennec Pharmaceuticals (NASDAQ:FENC) Stock Price Down 4.9%Fennec Pharmaceuticals (NASDAQ:FENC) Shares Down 4.9%September 17, 2024 | marketbeat.comFennec Pharmaceuticals to Participate in Upcoming Investor ConferencesSeptember 5, 2024 | globenewswire.comFennec Pharmaceuticals Inc (RV41.BE)August 30, 2024 | finance.yahoo.comResearch Analysts Set Expectations for Fennec Pharmaceuticals Inc's FY2024 Earnings (NASDAQ:FENC)Fennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Cantor Fitzgerald dropped their FY2024 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research report issued to clients and investors on Thursday, August 22nd. Cantor Fitzgerald analyst C. Duncan now expects that the comAugust 26, 2024 | marketbeat.comBuy Rating Affirmed for Fennec Pharmaceuticals Amidst PEDMARK’s Long-Term Growth PotentialAugust 22, 2024 | markets.businessinsider.comFennec Pharmaceuticals (NASDAQ:FENC) Price Target Cut to $13.00 by Analysts at HC WainwrightHC Wainwright decreased their price objective on shares of Fennec Pharmaceuticals from $15.00 to $13.00 and set a "buy" rating for the company in a report on Thursday.August 22, 2024 | marketbeat.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Analysts Are Reducing Their Forecasts For This YearAugust 21, 2024 | finance.yahoo.comCapital One Financial Research Analysts Cut Earnings Estimates for Fennec Pharmaceuticals Inc (NASDAQ:FENC)Fennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Stock analysts at Capital One Financial decreased their Q3 2024 earnings per share estimates for Fennec Pharmaceuticals in a report released on Tuesday, August 13th. Capital One Financial analyst N. Quibria now forecasts that the company wiAugust 16, 2024 | marketbeat.comFennec Pharmaceuticals Second Quarter 2024 Earnings: Misses ExpectationsAugust 15, 2024 | uk.finance.yahoo.comFennec Pharmaceuticals (NASDAQ:FENC) Releases Earnings Results, Misses Expectations By $0.26 EPSFennec Pharmaceuticals (NASDAQ:FENC - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.26). The business had revenue of $7.26 million for the quarter, compared to analyst estimates of $13.67 million. Fennec Pharmaceuticals had a negative return on equity of 39.41% and a net margin of 6.33%. During the same period in the prior year, the company posted ($0.21) earnings per share.August 15, 2024 | marketbeat.comFY2027 Earnings Estimate for Fennec Pharmaceuticals Inc (NASDAQ:FENC) Issued By Capital One FinancialFennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) - Stock analysts at Capital One Financial lowered their FY2027 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research note issued to investors on Tuesday, August 13th. Capital One Financial analyst N. Quibria now anticipaAugust 15, 2024 | marketbeat.comBuy Rating for Fennec Pharmaceuticals Bolstered by Pedmark’s Market Expansion and New LeadershipAugust 15, 2024 | markets.businessinsider.comVanguard Group Inc. Sells 126,437 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC)Vanguard Group Inc. trimmed its stake in Fennec Pharmaceuticals Inc (NASDAQ:FENC - Free Report) by 11.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,013,626 shares of the company's stock afterAugust 15, 2024 | marketbeat.comOptimistic Buy Rating for Fennec Pharmaceuticals Amidst Pedmark’s Market Expansion and Strong Financial OutlookAugust 15, 2024 | markets.businessinsider.comQ2 2024 Fennec Pharmaceuticals Inc Earnings Call TranscriptAugust 14, 2024 | gurufocus.com Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now FENC Media Mentions By Week FENC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FENC News Sentiment▼0.300.59▲Average Medical News Sentiment FENC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FENC Articles This Week▼152▲FENC Articles Average Week Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CARGO Therapeutics News Exscientia News Tourmaline Bio News ProKidney News Ginkgo Bioworks News Humacyte News Sangamo Therapeutics News MeiraGTx News Monte Rosa Therapeutics News Kodiak Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FENC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FENC Stock Alerts